Bayer Agreement

feature image
Bayer, a pharmaceutical group, announced that it has agreed to pay 10.1 - 10.9 billion dollars to resolve major outstanding Monsanto litigation, including U.S. Roundup product liability litigation, dicamba drift litigation and PCB water litigation. The company said: "The main feature is the U.S. Roundup resolution that will bring closure to approximately 75% of the current Roundup litigation involving approximately 125,000 filed and unfiled claims overall."
 

From a chartist’s point of view, the stock price is nearing the upper end of a short term bullish channel. The daily Relative Strength Index (RSI, 14) struck against its overbought area at 70% and is posting a consolidation move. The 20/50DMAs are ascending and should play a support role. The configuration is mixed. Investors have to remain cautious as these levels may trigger profit taking. Pullbacks to 65E can occur before prices can resume their up trend.  A break above 73.5E would open a path to see 78E. Alternatively, a break below 60E would invalidate the short term bullish bias.

Source: GAIN Capital, TradingView


Related tags: equities stocks

Open an account in minutes

Experience award-winning platforms with fast and secure execution.

Sign up for our interactive livestreams

Our interactive livestreams, led by our industry experts, come highly recommended and can help provide your trading with the edge it needs.
Economic Calendar